Macquarie Group
TDOC icon

Macquarie Group’s Teladoc Health TDOC Stock Holding History

Macquarie Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,445
Closed -$113K – 2099
2022
Q3 		$113K Sell
4,445
-73,086
-94% -$2.56M ﹤0.01% 1733
2022
Q2 		$2.57M Buy
77,531
+34,556
+80% +$1.47M ﹤0.01% 1209
2022
Q1 		$3.1M Buy
42,975
+729
+2% +$52.5K ﹤0.01% 1251
2021
Q4 		$3.88M Buy
42,246
+18,694
+79% +$2.23M ﹤0.01% 1187
2021
Q3 		$2.99M Sell
23,552
-572,497
-96% -$83.3M ﹤0.01% 1249
2021
Q2 		$99.1M Buy
596,049
+539,389
+952% +$87.4M 0.08% 309
2021
Q1 		$10.3M Buy
56,660
+15,058
+36% +$3.49M 0.01% 704
2020
Q4 		$8.32M Buy
41,602
+9,878
+31% +$2.01M 0.01% 762
2020
Q3 		$6.95M Sell
31,724
-259,955
-89% -$55M 0.01% 739
2020
Q2 		$55.7M Sell
291,679
-788,929
-73% -$138M 0.1% 232
2020
Q1 		$168M Sell
1,080,608
-921,103
-46% -$107M 0.34% 46
2019
Q4 		$168M Sell
2,001,711
-75,200
-4% -$5.72M 0.24% 65
2019
Q3 		$141M Buy
2,076,911
+586,104
+39% +$38.6M 0.24% 63
2019
Q2 		$99M Buy
1,490,807
+558,650
+60% +$32.6M 0.17% 107
2019
Q1 		$51.8M Sell
932,157
-193,118
-17% -$11.8M 0.09% 241
2018
Q4 		$55.8M Buy
1,125,275
+566,839
+102% +$34.7M 0.11% 182
2018
Q3 		$48.2M Buy
558,436
+459,422
+464% +$32.7M 0.08% 273
2018
Q2 		$5.75M Sell
99,014
-55,135
-36% -$2.69M 0.01% 747
2018
Q1 		$6.21M Sell
154,149
-26,873
-15% -$1.01M 0.01% 704
2017
Q4 		$6.31M Buy
181,022
+24,806
+16% +$824K 0.01% 734
2017
Q3 		$5.18M Buy
156,216
+37,566
+32% +$1.23M 0.01% 744
2017
Q2 		$4.12M Buy
118,650
+52,155
+78% +$1.52M 0.01% 797
2017
Q1 		$1.66M Buy
66,495
+8,421
+15% +$175K ﹤0.01% 1020
2016
Q4 		$958K Hold
58,074
– – ﹤0.01% 1169
2016
Q3 		$1.06M Sell
58,074
-26
-0% -$456 ﹤0.01% 1133
2016
Q2 		$931K Buy
+58,100
New +$678K ﹤0.01% 1160

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Macquarie Group's TDOC Position: Q4 2022 in Review

Macquarie Group sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 4,445 shares — an estimated $113K sold.

Macquarie Group first reported a position in TDOC in Q2 2016 and held it in 26 quarters. The position peaked at $168M in Q4 2019. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Macquarie Group reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 4,445 Teladoc Health shares in Q4 2022, an estimated $113K.
  • Macquarie Group first reported a position in Teladoc Health in Q2 2016 and held it in 26 quarters.
  • Macquarie Group's Teladoc Health position peaked at $168M in Q4 2019.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.